A newly approved immunotherapy was effective for some forms of rectal cancer without the need for additional treatments.

Fourteen years after being given just months to live, a pancreatic cancer survivor is sharing how a cutting-edge treatment ...

Two teens who experienced cancer — one as a caregiver and one as a patient — have launched a game-changing app, Soothe Note, ...

Five years ago, Lori Anderson's future looked bleak. Diagnosed with triple-negative breast cancer (TNBC), an aggressive form ...

The FDA has approved Tukysa (tucatinib) combined with trastuzumab and pertuzumab for the maintenance treatment of adult ...

Hargitay shared her thoughts with CURE regarding her father’s journey, her motivation for speaking out now, and the key message she wants to convey to patients today. Rob Lowe joins CURE Talks Cancer ...

The study, published in Proceedings of the National Academy of Sciences of the United States of America, deepens ...

Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent ...

Daraxonrasib, a drug developed by Dana-Farber Cancer Institute, works by blocking the specific gene mutations thought to drive abnormal cell growth in pancreatic cancer. The treatment has shown so ...

Dormant cancer cells may be sensitive to immune-driven changes in their surroundings. New findings reveal one molecular clue connecting inflammation with metastatic reactivation. Credit: Stock The ...

Lori Anderson, 57, was told she might have only two to five years left to live after her triple-negative breast cancer spread ...

Dolly Parton secretly traveled to Germany for an experimental cancer treatment approximately a year before her death. The country music legend reportedly flew to Frankfurt on a private jet to undergo ...